Kimberly-Clark Corp (XTER:KMY)
€ 125.4 -0.28 (-0.22%) Market Cap: 41.34 Bil Enterprise Value: 47.29 Bil PE Ratio: 17.28 PB Ratio: 34.59 GF Score: 74/100

Q2 2024 Kimberly-Clark Corp Earnings Call Transcript

Jul 23, 2024 / 12:00PM GMT
Release Date Price: €127.12 (-3.57%)

Key Points

Positve
  • Kimberly-Clark Corp (KMB) reported strong organic sales growth with positive volume trends.
  • The company made significant market share gains in key international markets, including China, the UK, South Korea, and Brazil.
  • Kimberly-Clark Corp (KMB) is effectively navigating external dynamics and driving a consumer-centric culture.
  • The company is on track to deliver its profit dollar objectives for the year, providing flexibility for further investments.
  • Kimberly-Clark Corp (KMB) has a robust innovation pipeline and is making strategic investments in its brands and technology.
Negative
  • The company faced unexpected headwinds from inventory destocking, particularly in North America.
  • There are ongoing challenges with supply constraints in certain categories, such as Scott 1,000 bath tissue.
  • Kimberly-Clark Corp (KMB) is exiting small markets like Nigeria and Bolivia, which may have short-term impacts on growth.
  • The company expects lower absolute dollar productivity delivery in the second half of the year.
  • There is increased consumer price sensitivity and promotional activity in the market, which may impact pricing and margins.
Operator

Good morning, and welcome to Kimberly-Clark second quarter 2024 earnings question-and-answer session. I will now hand the conference over to Chris Jakubik, Vice President and Investor Relations. Please go ahead.

Chris Jakubik
Kimberly-Clark Corp - Head of Investor Relations

Thank you, and hello, everyone. This is Chris Jakubik, Head of Global Investor Relations at Kimberly-Clark, and welcome to our Q&A session for our second quarter 2024 business update. During our remarks today, we will make some forward-looking statements that are based on how we see things today. Actual results may differ due to risks and uncertainties, and these are discussed in our earnings release and our filings with the SEC.

We will also make some non-GAAP financial measures today or discuss some non-GAAP financial measures today. And these non-GAAP financial measures should not be considered replacements for and should be read together with GAAP results. And you can find the GAAP to non-GAAP reconciliations within our earnings release and the supplemental materials posted

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot